Filing Details

Accession Number:
0001209191-15-043354
Form Type:
4
Zero Holdings:
No
Publication Time:
2015-05-15 16:30:08
Reporting Period:
2015-05-14
Filing Date:
2015-05-15
Accepted Time:
2015-05-15 16:30:08
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
816284 Celgene Corp CELG Pharmaceutical Preparations (2834) 222711928
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1187311 V Lawrence Stein C/O Celgene Corporation
86 Morris Avenue
Summit NJ 07901
See Remarks No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2015-05-14 2,542 $39.33 16,591 No 4 M Direct
Common Stock Disposition 2015-05-14 2,542 $114.85 14,049 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (right to buy) Disposition 2015-05-14 2,542 $0.00 2,542 $39.33
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
5,084 2022-12-03 No 4 M Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 519 Indirect 401(k) Plan
Footnotes
  1. The option was fully exercisable.
  2. The option was issued pursuant to the Celgene Corporation 2008 Stock Incentive Plan (amended and restated as of April 17, 2013).